Onisim Andrea, Achimas-Cadariu Andrei, Vlad Catalin, Kubelac Paul, Achimas-Cadariu Patriciu
"Prof. Dr. Ion Chiricuta" Institute of Oncology, Cluj-Napoca, Romania.
J BUON. 2015 May-Jun;20(3):699-706.
Tumor angiogenesis is regarded as a hallmark of cancer and provides an important target for therapy. Nestin is an intermediate filament protein (IF) originally recognized as a neural stem cell marker. Development and progression of cancer requires sustained angiogenesis, dependent on the proliferation and migration of endothelial cells which seem to be better portrayed by nestin expression in various malignancies such as central nervous system, gastro-intestinal cancers, malignant melanoma, lung, prostate or breast cancer. The purpose of the present review was to emphasize the insights into nestin expression in relation to tumor angiogenesis in different types of cancer. Current evidence suggests that nestin positivity in tumor cells reflects stem-like properties of those cells. Whether or not expressed in both tumor and endothelial cells, nestin overexpression might reflect the extent of angiogenesis and function as a molecular anti-angiogenic target for cancer.
肿瘤血管生成被视为癌症的一个标志,并为治疗提供了一个重要靶点。巢蛋白是一种中间丝蛋白(IF),最初被认为是神经干细胞标志物。癌症的发展和进展需要持续的血管生成,这依赖于内皮细胞的增殖和迁移,而巢蛋白在中枢神经系统、胃肠道癌症、恶性黑色素瘤、肺癌、前列腺癌或乳腺癌等各种恶性肿瘤中的表达似乎能更好地描述这一过程。本综述的目的是强调对不同类型癌症中巢蛋白表达与肿瘤血管生成关系的见解。目前的证据表明,肿瘤细胞中的巢蛋白阳性反映了这些细胞的干细胞样特性。无论巢蛋白是在肿瘤细胞还是内皮细胞中表达,其过表达可能反映血管生成的程度,并作为癌症的分子抗血管生成靶点发挥作用。